Gilead Sciences bags Pharmasset's hep C pipeline in $11B buyout We will see a huge premium.IMHO $100 a share. For a BP their Market Cap would increase in value for the price they paid since they bought a sure thing with area Civic08801
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.